Transcranial Ultrasound Via Sonolucent Cranioplasty
- Cranioplasty
- Sonolucent Cranioplasty
- Reconstructive Cranioplasty
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Northwell Health
- Enrolment target
- 50
- Started
- 27 June 2023
- Main results due
- 31 December 2028
- Study sites
- 1
- Registry updated
- 29 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: 1. Provision of signed and dated informed consent form. 2. Stated willingness to comply with all study procedures and availability for the duration of the study. 3. Patients who are undergoing reconstructive sonolucent cranioplasty as standard of care. 4. Male or female, aged ≥ 18. Exclusion Criteria: 1\. Patients who are pregnant
What this study is about
In the sponsor’s own words, from the registry.
Transcranial Ultrasound via Sonolucent Cranioplasty is a prospective, single arm, observational, open label (non-blinded) study to collect real world evidence on the use of transcranial ultrasound via sonolucent cranioplasty.
Study sites(1)
Lenox Hill Hospital
New York, New York, United States
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT06097845. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me